Skip to main content
All lobbying filings

S-3 GROUP

Lobbying for ALKERMES, INC. · Global biopharmaceutical company specializing in innovative treatments

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Income
$50,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 4
  • JOHN SCOFIELD
    Previously held: Comm Dir, House Approps, Press Sec., Rep LoBiondo
  • MARTIN DELGADO
    Previously held: Staff Dir, House Ag Approps, Prof Staff, Milcon/VA Approps
  • OLIVIA KURTZ
    Previously held: Chief of Staff, Leg Director, Dep Leg Director, Sr Leg Asst, US Sen Susan Collins; Dep Staff Dir, Sen Special Comm on Aging; Leg Director, Sr Leg Asst, Leg Asst, Exec Asst, Rep Mike Castle
  • ASHLEY DAVIS New on this filing
    Previously held: Special Assistant to the Homeland Security Director, Executive Office of the President; Deputy Director of Management and Administration, Executive Office of the President

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 1
Alcohol and Drug Abuse

Issues related to legislation and policies that support treatment for alcohol and opioid dependency at SAMSHA, VA and DOJ

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem